0001004878-17-000189.txt : 20170811
0001004878-17-000189.hdr.sgml : 20170811
20170811162942
ACCESSION NUMBER: 0001004878-17-000189
CONFORMED SUBMISSION TYPE: 424B3
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20170811
DATE AS OF CHANGE: 20170811
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEL SCI CORP
CENTRAL INDEX KEY: 0000725363
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 840916344
STATE OF INCORPORATION: CO
FISCAL YEAR END: 0930
FILING VALUES:
FORM TYPE: 424B3
SEC ACT: 1933 Act
SEC FILE NUMBER: 333-205444
FILM NUMBER: 171025492
BUSINESS ADDRESS:
STREET 1: 8229 BOONE BLVD .
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
BUSINESS PHONE: 7035069460
MAIL ADDRESS:
STREET 1: 8229 BOONE BLVD.
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
FORMER COMPANY:
FORMER CONFORMED NAME: INTERLEUKIN 2 INC
DATE OF NAME CHANGE: 19880317
424B3
1
prosupp424b3aug-17.txt
PRO SUPP RE SERIES DD WARRANT EXTENSION
PROSPECTUS SUPPLEMENT Filed pursuant to Rule 424(b)(3)
(To Prospectus Supplement Registration No. 333-205444
dated December 8, 2016)
CEL-SCI CORPORATION
Series DD Warrants
On August 9, 2017, the Company extended the expiration date of its Series DD
Warrants by one month from August 10, 2017 to September 10, 2017. The Series DD
warrants were issued as part of a financing on December 8, 2016. As a result of
the reverse stock split approved by the Company's shareholders and adopted by
the Company's directors, the holders of the Series DD warrants are entitled to
purchase 1,360,960 shares of the Company's common stock at an exercise price of
$4.50 per share.
..
Prospectus Supplement dated August 9, 2017